Disturbed sleep in pediatric patients with Leukemia: The Potential role of interleukin-6 (-174GC) and tumor necrosis factor (-308GA) polymorphism

Oncology Nursing Forum

Volumn 38, Issue 5, 2011, Pages

  Vallance, Kelly ^a   Yang, Jie ^e   Li, Jiang ^b   Crabtree, Valerie McLaughlin ^c   Hinds, Pamela S ^d   Mandrell, Belinda N ^c  

^a The Jane and John Justin Neuroscience Center   (United States)

^b Hartwell Center for Bioinformatics and Biotechnology   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^e Division of Nursing Research ^*

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052313543     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/11.ONF.E365-E372     Document Type: Article

References (43)

1. Aouizerat, B., Dodd, M., Lee, K., West, C., Paul, S., Cooper, B., , Miaskowski, C. (2009). Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biological Research for Nursing, 11, 27-41. doi:10.1177/ 1099800409333871.
2. Au, W.Y., Fung, A., Wong, K.F., Chan, C.H., & Liang, R. (2006). Tumor necrosis factor alpha promoter polymorphism and the risk of chronic lymphocytic leukemia and myeloma in the Chinese population. Leukemia and Lymphoma, 47, 2189-2193 doi:10.1080/10428190600758645. (Pubitemid 44650097)
3. Bel Hadj Jrad, B., Chatti, A., Laatiri, A., Ahmed, S.B., Romdhane, A., Ajimi, S., & Chouchane, L. (2007). Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas. European Journal of Haematology, 78, 117-122. doi:10.1111/j.1600- 0609.2006.00784.x. (Pubitemid 46058873)
4. Belluco, C., Olivieri, F., Bonafe, M., Giovagnetti, S., Mammano, E., Scalerta, R., , Lise, M. (2003). 174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clinical Cancer Research, 9, 2173-2176. (Pubitemid 36687640)
5. Bower, J.E., Ganz, P.A., Aziz, N., & Fahey, J.L. (2002). Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosomatic Medicine, 64, 604-611. (Pubitemid 34791163)
6. Cerhan, J.R., Liu-Mares, W., Fredericksen, Z.S., Novak, A.J., Cunningham, J.M., Kay, N.E., , Slager, S.L. (2008). Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin lymphoma. Cancer Epidemiology, Biomarkers and Prevention, 17, 3161-3169. doi:10.1158/1055-9965.EPI-08-0536.
7. Cleeland, C.S., Bennett, G.J., Dantzer, R., Dougherty, P.M., Dunn, A.J., Meyers, C.A., , Lee, B.N. (2003). Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer, 97, 2919-2925. doi:10.1002/cncr.11382. (Pubitemid 36605163)
8. Cox, E.D., Hoffmann, S.C., DiMercurio, B.S., Wesley, R.A., Harlan, D.M., Kirk, A.D., & Blair, P.J. (2001). Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation, 72, 720-726. (Pubitemid 32802759)
9. Duarte, I., Santos, A., Sousa, H., Catarino, R., Pinto, D., & Matos, A. (2005). G-308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer. Biochemical Biophysical Research Communications, 334, 588-592. doi:10.1016/j.bbrc.2005.06.137. (Pubitemid 40982407)
10. Fayad, L., Cabanillas, F., Talpaz, M., McLaughlin, P., & Kurzrock, R. (1998). High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma. Leukemia and Lymphoma, 30, 563-571. (Pubitemid 28393690)
11. Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J.S., Humphries, S., & Woo, P. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation, 102, 1369-1376. doi:10.1172/JCI2629. (Pubitemid 28467565)
12. Glaze, D.G. (2004). Childhood insomnia: Why Chris can't sleep. Pediatric Clinics of North America, 51, 33-50. doi:10.1016/S0031-3955 %2803%2900176-7. (Pubitemid 38121622)
13. Guo, W., Wang, N., Li, Y., & Zhang, J.H. (2005). Polymorphisms in tumor necrosis factor genes and susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high incidence region of North China. Chinese Medical Journal (English), 118, 1870-1878. (Pubitemid 41748746)
14. Hegedus, C.M., Skibola, C.F., Bracci, P., Holly, E.A., & Smith, M.T. (2007). Screening the human serum proteome for genotype-phenotype associations: An analysis of the IL6 -174G>C polymorphism. Proteomics, 7, 548-557. doi:10.1002/pmic.200600366. (Pubitemid 46362618)
15. Heitkemper, M., Levy, R., Jarrett, M., & Bond, E.F. (1995). Interventions for irritable bowel syndrome: A nursing model. Gastroenterology Nursing, 18, 224-230.
16. Heitkemper, M., & Shaver, J. (1989). Nursing research opportunities in enteral nutrition. Nursing Clinics of North America, 24, 415-426. (Pubitemid 19152109)
17. Hinds, P.S., Hockenberry, M., Rai, S.N., Zhang, L., Razzouk, B.I., Cremer, L., , Rodriguez-Galindo, C. (2007). Clinical field testing of an enhanced-activity intervention in hospitalized children with cancer. Journal of Pain and Symptom Management, 33, 686-697. (Pubitemid 46783988)
18. Hinds, P.S., Hockenberry, M., Rai, S.N., Zhang, L., Razzouk, B.I., McCarthy, K., , Rodriguez-Galindo, C. (2007). Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer. Oncology Nursing Forum, 34, 393-402. doi:10.1188/07.ONF.393-402.
19. Hinds, P.S., Hockenberry, M.J., Gattuso, J.S., Srivastava, D.K., Tong, X., Jones, H., , Pui, C.H. (2007). Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. Cancer, 110, 2321-2330. doi:10.1002/cncr.23039. (Pubitemid 350100755)
20. Hinds, P.S., Hockenberry-Eaton, M., Gilger, E., Kline, N., Burleson, C., Bottomley, S., & Quargnenti, A. (1999). Comparing patient, parent, and staff descriptions of fatigue in pediatric oncology patients. Cancer Nursing, 22, 277-288.
21. Hoffmann, S.C., Stanley, E.M., Cox, E.D., Craighead, N., DiMercurio, B.S., Koziol, D.E., , Blair, P.J. (2001). Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation, 72, 1444-1450. (Pubitemid 33015773)
22. Hoffmann, S.C., Stanley, E.M., Cox, E.D., DiMercurio, B.S., Koziol, D.E., Harlan, D.M., , Blair, P.J. (2002). Ethnicity greatly influences cytokine gene polymorphism distribution. American Journal of Transplantation, 2, 560-567. doi:10.1034/j.1600-6143.2002.20611.x. (Pubitemid 36306876)
23. Hong, S., Mills, P.J., Loredo, J.S., Adler, K.A., & Dimsdale, J.E. (2005). The association between interleukin-6, sleep, and demographic characteristics. Brain, Behavior, and Immunity, 19, 165-172. doi:10.1016/j.bbi.2004.07.008. (Pubitemid 40138651)
24. Jeanmonod, P., von Kanel, R., Maly, F.E., & Fischer, J.E. (2004). Elevated Plasma C-reactive protein in chronically distressed subjects who carry the A allele of the TNF-alpha -308 G/A polymorphism. Psychosomatic Medicine, 66, 501-506. (Pubitemid 38971243)
25. Kurzrock, R. (1997). Cytokine deregulation in hematological malignancies: Clinical and biological implications. Clinical Cancer Research, 3(12, Pt. 2), 2581-2584. (Pubitemid 28133109)
26. Kurzrock, R. (2001). The role of cytokines in cancer-related fatigue. Cancer, 92(6, Suppl.), 1684-1688. doi:10.1002/1097-0142(20010915). (Pubitemid 32939175)
27. Lee, B.N., Dantzer, R., Langley, K.E., Bennett, G.J., Dougherty, P.M., Dunn, A.J., , Cleeland, C.S. (2004). A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmu-nomodulation, 11, 279-292. doi:10.1159/000079408. (Pubitemid 39194326)
28. Littell, R. (2006). SAS for mixed models. Cary, NC: SAS Institute, Inc.
29. Meeske, K.A., Siegel, S.E., Globe, D.R., Mack, W.J., & Bernstein, L. (2005). Prevalence and correlates of fatigue in long-term survivors of childhood leukemia. Journal of Clinical Oncology, 23, 5501-5510. doi:10.1159/000079408.
30. Pelayo, R.P., Thorpy, M.J., & Glovinsky, P. (1988). Prevalence of delayed sleep phase syndrome among adolescents. Sleep Research, 17, 391.
31. Rich, T., Innominato, P.F., Boerner, J., Mormont, M.C., Iacobelli, S., Baron, B., & Levi, F. (2005). Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clinical Cancer Research, 11, 1757-1764. doi:10.1158/1078-0432.CCR-04-2000. (Pubitemid 40471837)
32. Riha, R.L., Brander, P., Vennelle, M., McArdle, N., Kerr, S.M., Anderson, N.H., & Douglas, N.J. (2005). Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnea-hypopnoea syndrome. European Respiratory Journal, 26, 673-678. doi:10.1183/09031936.05.00130804. (Pubitemid 41448667)
33. Rosen, G.M., Shor, A.C., & Geller, T.J. (2008). Sleep in children with cancer. Current Opinion in Pediatrics, 20, 676-681. doi:10.1097/MOP. 0b013e328312c7ad.
34. Sadeh, A., Sharkey, K.M., & Carskadon, M.A. (1994). Activity-based sleep-wake identification: An empirical test of methodological issues. Sleep, 17, 201-207. (Pubitemid 24174450)
35. Schiller, J.H., Storer, B.E., Witt, P.L., Alberti, D., Tombes, M.B., Arzoomanian, R., , Voss, S.D. (1991). Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly. Cancer Research, 51, 1651-1658.
36. Schubert, C., Hong, S., Natarajan, L., Mills, P.J., & Dimsdale, J.E. (2007). The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review. Brain, Behavior and Immunity, 21, 413-427. doi:10.1016/j.bbi.2006.11.004. (Pubitemid 46528677)
37. Vgontzas, A.N., Bixler, E.O., Lin, H.M., Prolo, P., Trakada, G., & Chrousos, G.P. (2005). IL-6 and its circadian secretion in humans. Neuroimmunomodulation, 12, 131-140. doi:10.1159/000084844. (Pubitemid 40868672)
38. Vgontzas, A.N., Papanicolaou, D.A., Bixler, E.O., Lotsikas, A., Zachman, K., Kales, A., , Chrousos, G.P. (1999). Circadian interleukin-6 secretion and quantity and depth of sleep. Journal of Clinical Endo-crinology and Metabolism, 84, 2603-2607. (Pubitemid 30641979)
39. Vgontzas, A.N., Zoumakis, E., Bixler, E.O., Lin, H.M., Follett, H., Kales, A., & Chrousos, G.P. (2004). Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. Journal of Clinical Endocrinology and Metabolism, 89, 2119-2126. (Pubitemid 38619840)
40. Vgontzas, A.N., Zoumakis, E., Lin, H.M., Bixler, E.O., Trakada, G., & Chrousos, G.P. (2004). Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. Journal of Clinical Endocrinology and Metabolism, 89, 4409-4413. (Pubitemid 39244447)
41. Wang, S.S., Cerhan, J.R., Hartge, P., Davis, S., Cozen, W., Severson, R.K., , Rothman, N. (2006). Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Research, 66, 9771-9780. doi:10.1158/0008-5472.CAN-06-0324. (Pubitemid 44623679)
42. Wilson, A.G., Symons, J.A., McDowell, T.L., McDevitt, H.O., & Duff, G.W. (1997). Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America, 94, 3195-3199. (Pubitemid 27157287)
43. Wood, L.J., Nail, L.M., Gilster, A., Winters, K.A., & Elsea, C.R. (2006). Cancer chemotherapy-related symptoms: Evidence to suggest a role for proinflammatory cytokines. Oncology Nursing Forum, 33, 535-542. doi: 10.1188/06.ONF.535-542. (Pubitemid 44870222)